Tag: axicabtagene ciloleucel

Home / axicabtagene ciloleucel

Categories

The FDA has granted axicabtagene ciloleucel expedited approval for relapsed or refractory follicular lymphoma.

August 2021: The FDA has given axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) expedited approval for adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines ...
axicabtagene-ciloleucel

Scan the code